Downregulation of LEMD1-AS1 and Its Influences on the Diagnosis, Prognosis, and Immune Infiltrates of Epithelial Ovarian Cancer
Open Access
- 3 August 2022
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2022, 1-8
Abstract
Previous studies have confirmed long noncoding RNA LEMD1-AS1 (LEMD1-AS1) as a functional factor in several tumors. The present work is aimed at exploring the prognostic and diagnostic values of LEMD1-AS1 in patients with epithelial ovarian cancer (EOC). We examined the expressions of LEMD1-AS1 in pan-cancer from TCGA microarray datasets and GTEx Project. The expressions of LEMD1-AS1 were detected by qRT-PCR in EOC specimens and normal ovarian specimens from 30 EOC patients. The test was applied to compare the clinicopathological characteristics of different groups. ROC curves were established to determine the diagnostic values of LEMD1-AS1 in screening EOC tissues. The association of LEMD1-AS1 expression with clinical outcome was determined by the Kaplan-Meier methods and COX assays. A decreased expression of LEMD1-AS1 was observed in EOC tissues compared to matched normal specimens ( ). Low LEMD1-AS1 expression could be used to distinguish EOC from adjacent normal specimens. A clinical study revealed that patients with low LEMD1-AS1 expression have a shorter overall survival ( ) and progress-free interval ( ) than those with high LEMD1-AS1 expression. The Spearman correlation test revealed that LEMD1-AS1 expressions were negatively associated with the expressions of neutrophil and myeloid dendritic cell. Overall, our finding suggested that LEMD1-AS1 may have potential roles as a potential biomarker and/or a therapeutic target in EOC.Keywords
Funding Information
- Precision Medicine Special Project (Special Nursing Project) of Hubei Province (ZLJZ2020HLYB007)
This publication has 26 references indexed in Scilit:
- Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203Aging, 2018
- Diagnosis and Treatment of Ovarian CancerHematology/Oncology Clinics of North America, 2018
- HOTAIR: An Oncogenic Long Non-Coding RNA in Human CancerCellular Physiology and Biochemistry, 2018
- Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human CancersCancer Discovery, 2018
- Improving immune–vascular crosstalk for cancer immunotherapyNature Reviews Immunology, 2018
- Long Noncoding RNAs in the Yeast S. cerevisiae2017
- Technological Developments in lncRNA Biology2017
- LncRNA-mediated regulation of cell signaling in cancerOncogene, 2017
- Molecular imaging in cervical cancer.2016
- On the classification of long non-coding RNAsRNA Biology, 2013